https://stock.noler.com/us/stock/9-meters-biopharma-inc https://stock.noler.com/us/stock/9-meters-biopharma-inc/accounts-payable https://stock.noler.com/us/stock/9-meters-biopharma-inc/accounts-receivable https://stock.noler.com/us/stock/9-meters-biopharma-inc/accrual-at-carrying-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/accrued-liabilities-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/accrued-marketing-costs-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/accrued-royalties-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/accumulated-depreciation https://stock.noler.com/us/stock/9-meters-biopharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/9-meters-biopharma-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/9-meters-biopharma-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/amortization https://stock.noler.com/us/stock/9-meters-biopharma-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/9-meters-biopharma-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/9-meters-biopharma-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/9-meters-biopharma-inc/aoci https://stock.noler.com/us/stock/9-meters-biopharma-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/9-meters-biopharma-inc/basic-shares https://stock.noler.com/us/stock/9-meters-biopharma-inc/bridge-loan https://stock.noler.com/us/stock/9-meters-biopharma-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/capital-expenditures https://stock.noler.com/us/stock/9-meters-biopharma-inc/cash https://stock.noler.com/us/stock/9-meters-biopharma-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/9-meters-biopharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/9-meters-biopharma-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/9-meters-biopharma-inc/cash-change https://stock.noler.com/us/stock/9-meters-biopharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/9-meters-biopharma-inc/certificates-of-deposit-at-carrying-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/9-meters-biopharma-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/9-meters-biopharma-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/9-meters-biopharma-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/9-meters-biopharma-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/9-meters-biopharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/9-meters-biopharma-inc/common-stock-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/9-meters-biopharma-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/9-meters-biopharma-inc/conversion-of-stock-shares-issued https://stock.noler.com/us/stock/9-meters-biopharma-inc/convertible-debt https://stock.noler.com/us/stock/9-meters-biopharma-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/9-meters-biopharma-inc/convertible-notes-payable https://stock.noler.com/us/stock/9-meters-biopharma-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/9-meters-biopharma-inc/cost-of-goods-sold https://stock.noler.com/us/stock/9-meters-biopharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/9-meters-biopharma-inc/current-assets https://stock.noler.com/us/stock/9-meters-biopharma-inc/current-liabilities https://stock.noler.com/us/stock/9-meters-biopharma-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/9-meters-biopharma-inc/customer-advances-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/customer-refund-liability-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/customer-refundable-fees-revenue-recognized https://stock.noler.com/us/stock/9-meters-biopharma-inc/damages-sought-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-carrying-amount https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-conversion-converted-instrument-warrants-or-options-issued https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-face-amount https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-unamortized-discount https://stock.noler.com/us/stock/9-meters-biopharma-inc/debt-unamortized-discount-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-compensation-liability-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-offering-costs https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-charitable-contribution-carryforwards https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-operating-loss-carryforwards-not-subject-to-expiration https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-operating-loss-carryforwards-subject-to-expiration https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-warranty-reserves https://stock.noler.com/us/stock/9-meters-biopharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/9-meters-biopharma-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/9-meters-biopharma-inc/depreciation https://stock.noler.com/us/stock/9-meters-biopharma-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/9-meters-biopharma-inc/derivative-liabilities https://stock.noler.com/us/stock/9-meters-biopharma-inc/derivative-liabilities-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/diluted-shares https://stock.noler.com/us/stock/9-meters-biopharma-inc/due-from-related-parties-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/due-to-affiliate-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/due-to-related-parties-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/9-meters-biopharma-inc/effective-tax-rate https://stock.noler.com/us/stock/9-meters-biopharma-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/eps https://stock.noler.com/us/stock/9-meters-biopharma-inc/eps-basic https://stock.noler.com/us/stock/9-meters-biopharma-inc/estimate-of-possible-loss https://stock.noler.com/us/stock/9-meters-biopharma-inc/extended-product-warranty-accrual-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/9-meters-biopharma-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/9-meters-biopharma-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/9-meters-biopharma-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/9-meters-biopharma-inc/fair-value-liabilities-change-in-unrealized-gain-loss https://stock.noler.com/us/stock/9-meters-biopharma-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-gain-loss-included-in-earnings https://stock.noler.com/us/stock/9-meters-biopharma-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-issues https://stock.noler.com/us/stock/9-meters-biopharma-inc/fair-value-net-derivative-asset-liability-with-unobservable-inputs https://stock.noler.com/us/stock/9-meters-biopharma-inc/financing-cash-flow https://stock.noler.com/us/stock/9-meters-biopharma-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/9-meters-biopharma-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/9-meters-biopharma-inc/form-d-corporate-securities https://stock.noler.com/us/stock/9-meters-biopharma-inc/form-d-other https://stock.noler.com/us/stock/9-meters-biopharma-inc/form-d-stocks https://stock.noler.com/us/stock/9-meters-biopharma-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/9-meters-biopharma-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/9-meters-biopharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/gross-profit https://stock.noler.com/us/stock/9-meters-biopharma-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/9-meters-biopharma-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/9-meters-biopharma-inc/income-tax https://stock.noler.com/us/stock/9-meters-biopharma-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/9-meters-biopharma-inc/income-taxes-paid https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/increase-decrease-of-restricted-investments https://stock.noler.com/us/stock/9-meters-biopharma-inc/induced-conversion-of-convertible-debt-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/insider-transactions-preferred https://stock.noler.com/us/stock/9-meters-biopharma-inc/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/9-meters-biopharma-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/9-meters-biopharma-inc/insider-transactions-warrants https://stock.noler.com/us/stock/9-meters-biopharma-inc/interest-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/9-meters-biopharma-inc/interest-expense-on-debt https://stock.noler.com/us/stock/9-meters-biopharma-inc/interest-income-other https://stock.noler.com/us/stock/9-meters-biopharma-inc/interest-paid-net https://stock.noler.com/us/stock/9-meters-biopharma-inc/interest-payable-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/inventory https://stock.noler.com/us/stock/9-meters-biopharma-inc/investing-cash-flow https://stock.noler.com/us/stock/9-meters-biopharma-inc/investment-income-interest https://stock.noler.com/us/stock/9-meters-biopharma-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/9-meters-biopharma-inc/lease-and-rental-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/9-meters-biopharma-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/9-meters-biopharma-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/9-meters-biopharma-inc/liabilities-assumed https://stock.noler.com/us/stock/9-meters-biopharma-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/9-meters-biopharma-inc/lines-of-credit-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/litigation-reserve-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/loans-payable-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/long-term-debt https://stock.noler.com/us/stock/9-meters-biopharma-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/9-meters-biopharma-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/9-meters-biopharma-inc/net-change-in-cash https://stock.noler.com/us/stock/9-meters-biopharma-inc/net-income https://stock.noler.com/us/stock/9-meters-biopharma-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/9-meters-biopharma-inc/notes-and-loans-payable-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/notes-payable https://stock.noler.com/us/stock/9-meters-biopharma-inc/notes-payable-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/number-of-operating-segments https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-cash-flow https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-expenses https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-income https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-lease-assets https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-lease-cost https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-lease-liability https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-lease-liability-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-lease-payments https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-lease-payments-due https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/9-meters-biopharma-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/9-meters-biopharma-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/other-commitment https://stock.noler.com/us/stock/9-meters-biopharma-inc/other-expenses https://stock.noler.com/us/stock/9-meters-biopharma-inc/other-income https://stock.noler.com/us/stock/9-meters-biopharma-inc/other-noncurrent-assets https://stock.noler.com/us/stock/9-meters-biopharma-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/other-notes-payable-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/9-meters-biopharma-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/9-meters-biopharma-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/9-meters-biopharma-inc/paid-in-capital-stock-split https://stock.noler.com/us/stock/9-meters-biopharma-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/9-meters-biopharma-inc/payment-for-management-fee https://stock.noler.com/us/stock/9-meters-biopharma-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/9-meters-biopharma-inc/payments-of-financing-costs https://stock.noler.com/us/stock/9-meters-biopharma-inc/payments-of-loan-costs https://stock.noler.com/us/stock/9-meters-biopharma-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/9-meters-biopharma-inc/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/9-meters-biopharma-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/9-meters-biopharma-inc/payments-to-acquire-restricted-certificates-of-deposit https://stock.noler.com/us/stock/9-meters-biopharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/9-meters-biopharma-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/9-meters-biopharma-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/9-meters-biopharma-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/9-meters-biopharma-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/9-meters-biopharma-inc/preferred-stock-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/preferred-stock-value-outstanding https://stock.noler.com/us/stock/9-meters-biopharma-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/prepaid-insurance https://stock.noler.com/us/stock/9-meters-biopharma-inc/pretax-income https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-collection-of-longterm-loans-to-related-parties https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-issuance-of-preferred-stock-preference-stock-and-warrants https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-other-short-term-debt https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-sale-of-restricted-investments https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/9-meters-biopharma-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/9-meters-biopharma-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/9-meters-biopharma-inc/property-plant-equipment https://stock.noler.com/us/stock/9-meters-biopharma-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/9-meters-biopharma-inc/public-float https://stock.noler.com/us/stock/9-meters-biopharma-inc/repayment-of-notes-receivable-from-related-parties https://stock.noler.com/us/stock/9-meters-biopharma-inc/repayments-of-debt https://stock.noler.com/us/stock/9-meters-biopharma-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/9-meters-biopharma-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/9-meters-biopharma-inc/repayments-of-other-short-term-debt https://stock.noler.com/us/stock/9-meters-biopharma-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/9-meters-biopharma-inc/research-and-development https://stock.noler.com/us/stock/9-meters-biopharma-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/9-meters-biopharma-inc/research-and-development-in-process https://stock.noler.com/us/stock/9-meters-biopharma-inc/restricted-cash https://stock.noler.com/us/stock/9-meters-biopharma-inc/restricted-cash-current https://stock.noler.com/us/stock/9-meters-biopharma-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/9-meters-biopharma-inc/restricted-stock-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/retained-earnings https://stock.noler.com/us/stock/9-meters-biopharma-inc/royalty-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/9-meters-biopharma-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/9-meters-biopharma-inc/security-deposit https://stock.noler.com/us/stock/9-meters-biopharma-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/severance-costs https://stock.noler.com/us/stock/9-meters-biopharma-inc/share-price https://stock.noler.com/us/stock/9-meters-biopharma-inc/shareholders-equity https://stock.noler.com/us/stock/9-meters-biopharma-inc/shares-authorized https://stock.noler.com/us/stock/9-meters-biopharma-inc/shares-issued https://stock.noler.com/us/stock/9-meters-biopharma-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/9-meters-biopharma-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/9-meters-biopharma-inc/shipping-handling-and-transportation-costs https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-based-compensation https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-option-plan-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-redeemed-or-called-value https://stock.noler.com/us/stock/9-meters-biopharma-inc/stock-split-ratio https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/9-meters-biopharma-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/9-meters-biopharma-inc/total-assets https://stock.noler.com/us/stock/9-meters-biopharma-inc/total-liabilities https://stock.noler.com/us/stock/9-meters-biopharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/9-meters-biopharma-inc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/9-meters-biopharma-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/9-meters-biopharma-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/9-meters-biopharma-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/9-meters-biopharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted